Literature DB >> 3202963

A new purification procedure of human kidney cathepsin H, its properties and kinetic data.

T Popović1, J Brzin, J Kos, B Lenarcic, W Machleidt, A Ritonja, K Hanada, V Turk.   

Abstract

A purification procedure of cathepsin H from human kidney is presented. It includes gel filtration, ion exchange chromatography, and covalent chromatography on thiol Sepharose as an essential step. Purified cathepsin H emerges in an isoelectric focusing gel at pH 6.1 and 6.3. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate shows a molecular mass of about 28 kDa. Less than 20% of the enzyme preparation can be separated into a heavy (24 kDa) and a light chain (4 kDa) after reduction and gel filtration on Sephacryl S-200. The partial amino-acid sequence of human cathepsin H shows its close similarity to rat cathepsin H. Inhibition constants (Ki) of cathepsins H and B with chicken cystatin, two forms of human stefin A, human stefin B, and two forms of human cystatin C are in the range of 10(-9) to 10(-11)M.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202963

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  4 in total

1.  Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.

Authors:  E Pol; I Björk
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

2.  A simple purification procedure of buffalo lung cathepsin H, its properties and influence of buffer constituents on the enzyme activity.

Authors:  Shalini Singh; Samir Sharma; Sudhir K Agarwal
Journal:  Biochem Biophys Rep       Date:  2020-02-09

3.  Studies on activation and inhibition of cathepsin B from buffalo liver.

Authors:  A Salahuddin; H Kaur
Journal:  J Protein Chem       Date:  1996-01

4.  The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.

Authors:  D Musil; D Zucic; D Turk; R A Engh; I Mayr; R Huber; T Popovic; V Turk; T Towatari; N Katunuma
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.